Hospira Oxaliplatin Injection 100 mg/20 mL vial

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

oxaliplatin, Quantity: 5 mg/mL

Available from:

Hospira Australia Pty Ltd

INN (International Name):

Oxaliplatin

Pharmaceutical form:

Injection, intravenous infusion

Composition:

Excipient Ingredients: tartaric acid; sodium hydroxide; water for injections

Administration route:

Intravenous

Units in package:

1 x 20 mL

Class:

Medicine Listed (Export Only)

Prescription type:

(S1) This Schedule is intentionally blank

Therapeutic indications:

Oxaliplatin, used in combination with infusional 5-fluorouracil/leucovorin is indicated for: * Adjuvant treatment of stage III colon cancer in patients who have undergone complete resection of the primary tumour * Treatment of advanced colorectal cancer.

Product summary:

Visual Identification: Clear colourless solution practically free of particles; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 18 Months; Container Temperature: Store between 20 - 25 degrees celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Authorization status:

Licence status A

Authorization date:

2013-03-25